Prepared by FDA's Office of Planning and Evaluation in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER)
prepared by FDA's Office of Planning and Evaluation in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER)
Performance valuation of accreditation bodies under the Mammography Quality Standards Act of 1992 as amended by the Mammography Quality Standards Reauthorization Act of 1998, a report to Congress (Online)